Navigation Links
Philips Supports the Boston Marathon as the Sole Provider of Life-Saving Medical Devices
Date:4/18/2008

Automated external defibrillators and advanced life support

monitor/defibrillators help ensure safety at 112th Boston Marathon

ANDOVER, Mass., April 18 /PRNewswire-FirstCall/ -- Royal Philips Electronics (NYSE: PHG, AEX: PHI) today announced its role as the sole provider of automated external defibrillators (AEDs) and advanced life support (ALS) monitor/defibrillators for the 112th Boston Marathon, which will be run on April 21. The strategic deployment of Philips HeartStart AEDs and ALS monitor/defibrillators will equip the Boston Marathon Medical Team to respond promptly to the medical needs of runners and spectators alike.

Philips will provide 31 HeartStart MRx Monitor/Defibrillators and 36 HeartStart AEDs to cover the race, including along the course and at first aid stations, medical tents and Red Cross stations. These devices will be in steady use, or at the ready, to support the more than 1,200 medical and nursing personnel that will staff the event.

The HeartStart MRx Monitor/Defibrillator provides advanced functionality with the fastest time to shock of any monitor/defibrillator and the ability to support healthcare professionals in diagnosing both routine and critical conditions, such as acute myocardial infarction (heart attack). The MRx is sure to be a widely used tool for the Boston Marathon Medical Team as it provides the technology to monitor and assess patients, including measuring heart rate, blood pressure and oxygen saturation, among other vital signs. A common risk for marathon runners is the onset of hyper- or hypothermia, conditions that require immediate diagnosis and treatment. The HeartStart MRx is the only device of its class equipped with on-board continuous temperature monitoring,
'/>"/>

SOURCE Royal Philips Electronics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
2. Audio from Medialink and Philips: Americas Dirty Mouths
3. AUDIO from Medialink and Philips: Getting Rid of the Uninvited Holiday Guests on Your Toothbrush
4. North Carolina Coalition on Donation Selects Corder Philips for Newest Campaign
5. Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share
6. VIDEO from Medialink and Philips: Philips Electronics Unveils First Imagination Light Canvas at the New Mercy Medical Center in Rogers AR
7. HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming
8. Diageo Supports First Ever National We Dont Serve Teens Week
9. The Prem Rawat Foundation Supports Disaster-Relief Efforts in Mozambique
10. Discovery supports theory of Alzheimers disease as form of diabetes
11. Study Supports Change to Prostate Cancer Biopsy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., Nov. 27 Preventing di...d fortunately every year, new vaccines are being a...accines boost immunity for the same period of time... needed to keep immunity strong? ,, In this m...rican Academy of Pediatrics, Michael Pichichero MD...
(Date:11/27/2009)...enaCare Holdings has announced that it has become ...e of the largest nonprofit organizations dedicated.... , Delray Beach, FL (Voc...OTCBB: XCHO), a company specializing in the market... products, has announced today that is has become ...
(Date:11/27/2009)... SEATTLE, Nov. 27 Allrecipes.com ... Thanksgiving traffic numbers, with more than 2.8 ...iding a clear picture of what was served on the bi...giving meal in 2009 weighed in at 2,225 calories p...feast. According to the Allrecipes site, Sweet Po...
(Date:11/27/2009)...pecialist manufacturers who use medical load cells...s of dollars by bringing in technology partner Fli...rs of pro-active medical manufacturers are calling... of their projects, ensuring that progress will no...otentially outdated technology. , ...
(Date:11/26/2009)...J., Nov. 27 The diabetes populatio... next 25 years and annual medical spending on the ...$113 billion today, according to a study published...tional Changing Diabetes ® Program (NCDP), a...s by a team from the University of Chicago. ,, ...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4
...art Inc. announced,that the first DuraHeart(TM) Le...in October at the University of Tokyo Hospital in ...ward an early application for approval,for manufac...etically levitated,impeller. The product received ...
...evenue Guidance, HOUSTON, Oct. 31 Cyberonics, In... for Medicare and Medicaid Services,(CMS) has publ...System,(OPPS) Final Rule and Ambulatory Payment Cl...erapy generators and $7,234,for insertion of assoc...
... and Asia-Pacific trials to be, presented at 59th ... Study of Liver Diseases ...ayer HealthCare Pharmaceuticals, Inc. and Onyx Pha...ation for the Study,of Live Diseases (AASLD) demon...
... nurtures creative,thinking. In this time of econo...mers, and employees, innovations in marketing, sal...market share., Network with and learn from leadin...Enable Companies to Survive and Thrive,During the ...
...ing nerves, waking people from a coma, 6 year chro...tigue/fibromyalgia, whiplash, carpel tunnel, and r...using advanced magnetic therapy techniques develop... year chronic sciatica back pain, 15- and 25-year ...
...shed finds that, while about 40 percent of women s...cent indicate that those issues are a source of si...Massachusetts General Hospital (MGH) physician app...se which are truly bothersome and affect a woman,s...
Other Medicine News:Health News:Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS 2Health News:Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS 3Health News:New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer 2Health News:New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer 3Health News:New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer 4Health News:New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer 5Health News:New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer 6Health News:Survive the Economic Downturn Through Innovations in Integrated Customer Strategies 2Health News:BiomagScience Introduces Breakthrough Health Therapy Kits 2Health News:BiomagScience Introduces Breakthrough Health Therapy Kits 3Health News:BiomagScience Introduces Breakthrough Health Therapy Kits 4Health News:BiomagScience Introduces Breakthrough Health Therapy Kits 5Health News:While prevalent, sexual problems in women not always associated with distress 2
(Date:11/25/2009)... SAN DIEGO, Nov. 25 NuVa...any focused on developing products for minimally d...nced today that it will host a conference call on ...p.m. PT. The conference call will focus on curren...,s products and will include comments from managem...
(Date:11/25/2009)...EW YORK, Nov. 25 Reportlinker.com ...ilable in its catalogue: ,, Intranasal Drug De...www.reportlinker.com/p0164267/Intranasal-Drug-Deli...US intranasal drug delivery market is witnessing a...elivery of conventional local therapeutic drugs to...
(Date:11/25/2009)... VIEW, Calif., Nov. 25 ChemoCent...cal data from the Company,s PROTECT-1 (the Prospec... disease Trial) of Traficet-EN(TM) (CCX282-B) in p...monstrated clinical efficacy with a favorable safe...ed evidence of clinical efficacy in the reduction ...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Dense Breasts Raise Risk of Cancer Recurrence 60997 1Dense Breasts Raise Risk of Cancer Recurrence 60997 2Dense Breasts Raise Risk of Cancer Recurrence 60997 3Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 60994 1Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 60994 2Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 60994 3American Academy of Physician Assistants Applauds U S House of Representatives for Passing Health Care Reform Bill 60989 1American Academy of Physician Assistants Applauds U S House of Representatives for Passing Health Care Reform Bill 60989 2
... 09, 2007 /PRNewswire-FirstCall/ --,Telik, Inc. an...enter Phase 2 trial of the triplet combination of ... and paclitaxel will be,presented at the 98th annu...Research (AACR) in Los Angeles. Preclinical studie...tic cancer cell growth,inhibition with TELCYTA in ...
...SS WIRE)--Apr 11, 2007 - New data,supporting the c...,the most advanced investigational oral protease i...HCV) infection, will be presented,at the 42nd Annu...dy of the Liver (EASL) in Barcelona this week. In ...een accepted for presentation,at the EASL conferen...
Other Medicine Technology:Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 2Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 3Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 2Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 3Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 4Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 5Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 6
ACE SCFE Screw
4.0 mm and 6.5 mm Cannulated Screws
...bles fixation of humeral shaft fractures while avo...associated with antegrade nailing. , ,In addition,...ng using a nail-mounted targeting device. This dev...th the patient in the prone position. In cases tha...
...edical technology company and a key participant in...es a new generation Automated Coagulation Timer. T...electromechanical coagulation instrument designed ... citrated whole blood, and plasma samples. Clottin...
Medicine Products: